SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Xbrane Biopharma Q3 Loss Narrows 51% to SEK 11.7 Million

The company reported Q3 revenue of SEK 54.8 million, up from an unspecified comparison period.

Related stories